Compare AbCellera Biologics Inc (ABCL) vs Freeport-McMoRan Inc (FCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Freeport-McMoRan Inc — how do they compare? AbCellera Biologics Inc trades at $10.94 (market cap $3.17B), while Freeport-McMoRan Inc trades at $66.82 (market cap $96.91B). The key difference: Freeport-McMoRan Inc is far larger — about 30.6× AbCellera Biologics Inc's market cap, and Freeport-McMoRan Inc pays a 0.87% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | FCX | |
|---|---|---|
Market Cap | $3.17B | $96.91B |
Sector | Health | Basic Materials |
52-Week High | $10.36 | $71.73 |
52-Week Low | $2.78 | $35.34 |
Enterprise Value | $2.77B | $103.19B |
Dividend Yield | — | 0.87% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Freeport-McMoRan Inc
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →
